Modular complement assemblies for mitigating inflammatory conditions

Significance Current treatments for chronic inflammatory conditions rely on biologic drugs, commonly monoclonal antibodies that interfere with inflammatory signaling pathways. These drugs have made enormous contributions to the treatment of inflammatory diseases but still possess considerable drawbacks, including high cost that limits access in low-resource settings, the requirement for regularly repeated injections, and uneven efficacy. As an...